Header Logo

Erin Farlow

Concepts (47)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
4
2011
216
0.740
Why?
Lung Neoplasms
4
2011
505
0.630
Why?
Autoantibodies
2
2010
71
0.420
Why?
Early Detection of Cancer
2
2010
85
0.410
Why?
Blood Chemical Analysis
1
2010
13
0.360
Why?
Hematologic Tests
1
2010
6
0.360
Why?
Protein Array Analysis
1
2010
10
0.350
Why?
Algorithms
3
2010
358
0.170
Why?
Biomarkers, Tumor
2
2010
179
0.160
Why?
Cohort Studies
3
2011
1815
0.090
Why?
Neoadjuvant Therapy
1
2011
63
0.090
Why?
Serum
1
2010
7
0.090
Why?
Pneumonectomy
1
2011
67
0.090
Why?
Antibodies, Neoplasm
1
2010
13
0.090
Why?
Antigens, Neoplasm
1
2010
38
0.090
Why?
Lymphatic Metastasis
1
2010
80
0.090
Why?
Cell Line, Tumor
1
2010
230
0.080
Why?
Proteomics
1
2010
91
0.080
Why?
Adenocarcinoma
1
2010
123
0.080
Why?
Mediastinal Neoplasms
1
2009
11
0.080
Why?
Case-Control Studies
1
2010
546
0.080
Why?
Gastrointestinal Stromal Tumors
1
2009
29
0.080
Why?
Esophageal Neoplasms
1
2009
43
0.080
Why?
Adult
3
2011
7351
0.060
Why?
Aged, 80 and over
2
2010
4661
0.060
Why?
Humans
5
2011
25967
0.060
Why?
Middle Aged
3
2011
8508
0.050
Why?
Aged
3
2011
8704
0.050
Why?
Male
4
2011
13984
0.050
Why?
Female
3
2011
14351
0.040
Why?
Treatment Outcome
2
2011
3292
0.020
Why?
Radiotherapy, Adjuvant
1
2011
42
0.020
Why?
Chemotherapy, Adjuvant
1
2011
70
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
10
0.020
Why?
Kaplan-Meier Estimate
1
2011
161
0.020
Why?
Survival Analysis
1
2011
235
0.020
Why?
Tandem Mass Spectrometry
1
2010
21
0.020
Why?
Analysis of Variance
1
2011
253
0.020
Why?
Multivariate Analysis
1
2011
293
0.020
Why?
Proportional Hazards Models
1
2011
326
0.020
Why?
Neoplasm Staging
1
2011
313
0.020
Why?
Risk Assessment
1
2011
621
0.020
Why?
Follow-Up Studies
1
2011
1710
0.020
Why?
Postoperative Complications
1
2011
862
0.020
Why?
Tomography, X-Ray Computed
1
2009
713
0.020
Why?
Magnetic Resonance Imaging
1
2009
1140
0.010
Why?
Retrospective Studies
1
2011
3290
0.010
Why?
Farlow's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (47)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_